HBM Holdings Limited

OVERVALUEDHBMHF · OTC · Healthcare
HBMHF·OTC·Healthcare
OVERVALUED
HBM Holdings Limited
21.8%downside
MARKET PRICE
$1.56
FAIR PRICE
$1.22
MARGIN
$0.34
UNDERVALUEDFAIROVERVALUED
P/E RATIO
433.3x
DIV. YIELD
N/A
ROE
N/A
MARKET CAP
$1B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

21.8%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$1.56

FAIR PRICE

$1.22

MARGIN

$0.34

UNDERVALUEDFAIROVERVALUED

P/E Ratio

433.3x

What is P/E? →

Div. Yield

N/A

ROE

N/A

Market Cap

$1B

Small-cap

NOW AVAILABLE

Get notified when HBMHF's fair price changes

Push notifications when HBMHF's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

4.9/ 10

Consistent growth trajectory and low debt levels, but volatile earnings pattern and below-average fundamental quality.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$0.98CONSERVATIVE ENTRY
$1.22FAIR PRICE
$1.56MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$0.98

Fair price × 0.80

DISTANCE

37.4%

Price to entry level

At the current price of $1.56, HBMHF trades 37.4% above the conservative entry level of $0.98. This entry level represents a 20% margin of safety below the calculated fair price of $1.22 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate HBMHF's fair price

HBM Holdings Limited's fair price of $1.22 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $1.56, HBMHF trades 21.8% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting HBMHF's risk profile.

RELATIVE · 30%

Comparing HBMHF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for HBMHF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate HBMHF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for HBMHF.

Explore on Bulios

FAQ

What is the fair price of HBMHF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for HBM Holdings Limited is $1.22. At the current market price of $1.56, HBMHF trades 21.8% above its calculated fair value.

Is HBMHF overvalued or undervalued?+

HBM Holdings Limited is currently overvalued based on our valuation model. The stock trades at $1.56, which is 21.8% above the fair price of $1.22. The P/E ratio of 433.3x is a key metric in the valuation.

What is the margin of safety for HBMHF?+

With a 20% margin of safety applied to the fair price of $1.22, the conservative entry level for HBMHF is $0.98. At the current market price of $1.56, the stock trades 37.4% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is HBMHF's fair price updated?+

We update fair price calculations for HBMHF daily after market close. The current fair price of $1.22 incorporates the latest market data and sector multiples.

What factors affect HBMHF's fair price calculation?+

HBMHF's fair price of $1.22 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 433.3x.

Is HBMHF a good buy right now?+

At $1.56, HBMHF trades 21.8% above our fair value estimate of $1.22. The stock is currently overvalued. Fair Price Index provides valuation data — always do your own research before investing.

Does HBMHF pay dividends?+

HBMHF does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.